Repligen (RGEN) Other Accumulated Expenses (2011 - 2026)

Repligen (RGEN) has reported Other Accumulated Expenses for 15 consecutive years, with $25.9 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Other Accumulated Expenses rose 41.74% year-over-year to $25.9 million; the TTM figure through Jun 2026 stood at $25.9 million (up 41.74% YoY), while the FY2025 annual figure was $20.9 million, up 33.81% from the prior year.
• Other Accumulated Expenses advanced to $25.9 million in Q2 2026 per RGEN's latest filing, from $19.8 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $25.9 million in Q2 2026 and bottomed at $14.7 million in Q2 2023.
• Historically, Other Accumulated Expenses has averaged $18.2 million across 5 years, with a median of $17.3 million in 2022.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses surged 1090.58% — and 2023, when it decreased 13.08%.
• Repligen's Other Accumulated Expenses stood at $15.9 million in 2022, then increased by 5.78% to $16.8 million in 2023, then slipped by 7.02% to $15.6 million in 2024, then jumped by 33.81% to $20.9 million in 2025, then climbed by 23.97% to $25.9 million in 2026.
• Business Quant data shows RGEN's Other Accumulated Expenses at $25.9 million in Q2 2026, $19.8 million in Q1 2026, and $20.9 million in Q4 2025.